Companies: 10,795·Total market cap: $144.5T
Bionovate Technologies Corp

Bionovate Technologies Corp

BIIOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$775
P/E Ratio—
52W High$0.0001
52W Low$0.0001
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Bionovate Technologies Corp (BIIO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001575420 · BIIO · OTC · as of Jun 8, 2026

Filing snapshot

84
Total Filings
8-K
Latest Form
2022-02-01
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001575420 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2021-10-14
Fiscal Year End
Oct 14, 2021
Accession No.
0001640334-21-002564
Primary Document
biio_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001575420 · Accession 0001640334-21-002564

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2022-02-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2022-02-01
View
10-QQuarterly Report
FORM 10-Q
2021-11-15
View
10-KAnnual Report
FORM 10-K
2021-10-14
View
NT 10-KNT 10-K
NT 10-K
2021-09-29
View
8-KCurrent Report
FORM 8-K
2021-07-14
View
10-QQuarterly Report
Quarterly Report
2021-05-17
View
10-QQuarterly Report
FORM 10-Q
2021-01-28
View
10-QQuarterly Report
FORM 10-Q
2020-11-23
View
NT 10-QNT 10-Q
NT 10-Q
2020-11-16
View
8-K/ACurrent Report (Amended)
FORM 8-K/A
2020-10-26
View
10-KAnnual Report
FORM 10-K
2020-10-19
View
8-KCurrent Report
FORM 8-K
2020-10-13
View
8-KCurrent Report
FORM 8-K
2020-10-06
View
SC 13DActivist Ownership Report
SC 13D
2020-10-06
View
NT 10-KNT 10-K
NT 10-K
2020-09-29
View
Showing 1–15 of 84 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001575420  |  Exchange: OTC · Healthcare

Bionovate Technologies Corp (OTC: BIIO) has submitted 84 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001575420, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Bionovate Technologies Corp's most comprehensive regulatory disclosure. The most recent Bionovate Technologies Corp 10-K was filed on 2021-10-14 for fiscal year ending 2021. Historical BIIO 10-K annual reports are available from 2013 through 2021.

Investors researching Bionovate Technologies Corp SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
PJET SEC Filings →LITH SEC Filings →AMHD SEC Filings →MMTC SEC Filings →UTRS SEC Filings →PROT SEC Filings →ATRX SEC Filings →OTRKQ SEC Filings →
→ BIIO Financials→ BIIO Earnings→ BIIO Insider Trades

Frequently Asked Questions

BIIO SEC Filings · 8 questions

Bionovate Technologies Corp (BIIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 84 filings and access original documents at no cost. Bionovate Technologies Corp's CIK is 0001575420.

BIIO SEC filingsBionovate Technologies Corp SEC documentsfind BIIO 10-K